Slovenian
Albanian
Arabic
Armenian
Azerbaijani
Belarusian
Bengali
Bosnian
Catalan
Czech
Danish
Deutsch
Dutch
English
Estonian
Finnish
Français
Greek
Haitian Creole
Hebrew
Hindi
Hungarian
Icelandic
Indonesian
Irish
Italian
Japanese
Korean
Latvian
Lithuanian
Macedonian
Mongolian
Norwegian
Persian
Polish
Portuguese
Romanian
Russian
Serbian
Slovak
Slovenian
Spanish
Swahili
Swedish
Turkish
Ukrainian
Vietnamese
Български
中文(简体)
中文(繁體)

serotonin/možganska kap

Povezava se shrani v odložišče
Stran 1 iz 663 rezultatov

Platelet serotonin transporter in stroke patients.

Samo registrirani uporabniki lahko prevajajo članke
Prijava / prijava
OBJECTIVE Post-stroke depression can be treated with serotonin transport inhibitors suggesting a role for the serotonin system in these patients. The number of platelet serotonin transporters in stroke patients and in control subjects have been measured in this study. METHODS Newly admitted stroke
OBJECTIVE To investigate the plasma and cerebrospinal fluid (CSF) concentrations of serotonin in patients with post-stroke depression (PSD). METHODS Serotonin was measured in 30 PSD patients and 30 controls on day 15 and day 30 following stroke. RESULTS There was a good correlation between the
BACKGROUND Previous research has suggested a link between antidepressants use and the development of cerebrovascular events, but there has never been any study investigating the risk of stroke in obsessive-compulsive disorder (OCD) patients treated with a selective serotonin reuptake inhibitor

Selective serotonin reuptake inhibitors and risk of hemorrhagic stroke.

Samo registrirani uporabniki lahko prevajajo članke
Prijava / prijava
OBJECTIVE Selective serotonin reuptake inhibitors (SSRI) are widely prescribed. Several reports have observed an increased bleeding risk associated with SSRI use, which is hypothesized to be secondary to their antiplatelet effect. METHODS We tested the hypothesis that SSRIs increase the risk for or

Therapeutic effects of milnacipran, a serotonin and noradrenaline reuptake inhibitor, on post-stroke depression.

Samo registrirani uporabniki lahko prevajajo članke
Prijava / prijava
Depression is common after stroke. While several reports have been published on the use of antidepressants such as selective serotonin reuptake inhibitors and tricyclics for the treatment of post-stroke depression (PSD), no previous study has examined the use of a selective serotonin and

Is left stroke a risk-factor for selective serotonin reuptake inhibitor antidepressant treatment resistance?

Samo registrirani uporabniki lahko prevajajo članke
Prijava / prijava
The objective of the study was to detect changes of depression and cognitive level associated with right and left brain damage during SSRI treatment in subjects with post-stroke Major Depressive Disorder (MDD). After the baseline evaluation, the 45 patients included received a single oral dose of
OBJECTIVE This study aimed to determine whether the degree of serotonin (5-HT) reuptake inhibition affects risk of hemorrhagic stroke associated with antidepressant use in patients with depression. METHODS A population-based, nested case-control study was performed using a managed care medical

Fluoxetine-induced recovery of serotonin and norepinephrine projections in a mouse model of post-stroke depression

Samo registrirani uporabniki lahko prevajajo članke
Prijava / prijava
Chronic treatment with fluoxetine (FLX) is required for its antidepressant effects, but the role of serotonin (5-HT) axonal plasticity in FLX action is unknown. To address this, we examined mice with a stroke in the left medial prefrontal cortex (mPFC) resulting in persistent anxiety-like and
Selective serotonin-reuptake inhibitors (SSRIs) impair platelet function and have been linked to a higher risk of spontaneous intracerebral hemorrhage-an association that may be augmented by oral anticoagulants (OAC). We aimed to assess whether preadmission treatment with SSRIs in patients with
OBJECTIVE To investigate the effects of single doses of a selective serotonin reuptake inhibitor (SSRI) on lower limb voluntary and reflex function in individuals with chronic stroke. METHODS Double-blind, randomized, placebo-controlled crossover trial. METHODS Outpatient research

Extended evaluation of serotonin transporter gene functional polymorphisms in subjects with post-stroke depression.

Samo registrirani uporabniki lahko prevajajo članke
Prijava / prijava
OBJECTIVE As an extension of our previous observation, relating a serotonin transporter gene-linked promoter region (5-HTTLPR) diallelic functional polymorphism (short [S] and long [L] alleles) to the risk of post-stroke major depression (PSD), this study investigated the role of 2 other functional

Spontaneous remission of post-stroke depression and temporal changes in cortical S2-serotonin receptors.

Samo registrirani uporabniki lahko prevajajo članke
Prijava / prijava
A patient with post-stroke depression following infarction of the left basal ganglia is described. The patient's depression remitted during a 6-week double-blind treatment trial while receiving placebo medication. Cortical S2-receptor binding that was measured using 11C-N methyl spiperone and

PET imaging of cortical S2 serotonin receptors after stroke: lateralized changes and relationship to depression.

Samo registrirani uporabniki lahko prevajajo članke
Prijava / prijava
Patients with right-hemisphere strokes (N = 9) more than 1 year after injury had greater cortical binding of (3-N-[11C]methyl)spiperone than a similar group of patients with left-hemisphere strokes (N = 8) or normal control subjects (N = 17). The higher S2 serotonin receptor binding occurred in

Polymorphisms of the serotonin transporter gene and post-stroke depression: a meta-analysis.

Samo registrirani uporabniki lahko prevajajo članke
Prijava / prijava
BACKGROUND Polymorphisms of the gene encoding the serotonin transporter-specifically, length variation in the serotonin--transporter-linked polymorphic region (5-HTTLPR), a single-nucleotide polymorphism in the 5-HTTLPR (rs25531), and variable number of tandem repeats (VNTR) in the second intron 2

A preliminary study of cortical S2 serotonin receptors and cognitive performance following stroke.

Samo registrirani uporabniki lahko prevajajo članke
Prijava / prijava
Cortical serotonin receptor binding was measured with positron-emission tomography (PET) in uninjured regions of cortex in 26 stroke patients. Cognitive function was assessed with the Mini-Mental State Exam (MMSE) and a neuropsychological test battery. Left frontal cortex serotonin binding was
Pridružite se naši
facebook strani

Najbolj popolna baza zdravilnih zelišč, podprta z znanostjo

  • Deluje v 55 jezikih
  • Zeliščna zdravila, podprta z znanostjo
  • Prepoznavanje zelišč po sliki
  • Interaktivni GPS zemljevid - označite zelišča na lokaciji (kmalu)
  • Preberite znanstvene publikacije, povezane z vašim iskanjem
  • Iščite zdravilna zelišča po njihovih učinkih
  • Organizirajte svoje interese in bodite na tekočem z raziskavami novic, kliničnimi preskušanji in patenti

Vnesite simptom ali bolezen in preberite o zeliščih, ki bi lahko pomagala, vnesite zelišče in si oglejte bolezni in simptome, proti katerim se uporablja.
* Vse informacije temeljijo na objavljenih znanstvenih raziskavah

Google Play badgeApp Store badge